Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,101 | 51 | 97.2% |
| Education | $32.27 | 1 | 2.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $331.83 | 10 | $0 (2023) |
| Merck Sharp & Dohme LLC | $208.18 | 11 | $0 (2024) |
| AbbVie Inc. | $78.33 | 3 | $0 (2023) |
| Organon LLC | $65.54 | 4 | $0 (2023) |
| Allergan, Inc. | $60.18 | 4 | $0 (2020) |
| Hologic, LLC | $56.71 | 3 | $0 (2019) |
| Novo Nordisk Inc | $55.98 | 2 | $0 (2024) |
| GlaxoSmithKline, LLC. | $55.44 | 3 | $0 (2023) |
| SANOFI PASTEUR INC. | $41.15 | 2 | $0 (2022) |
| Cranial Technologies, Inc | $32.27 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $81.04 | 3 | Novo Nordisk Inc ($55.98) |
| 2023 | $167.89 | 7 | Novartis Pharmaceuticals Corporation ($52.15) |
| 2022 | $229.06 | 10 | Novartis Pharmaceuticals Corporation ($69.56) |
| 2021 | $149.43 | 9 | Merck Sharp & Dohme Corporation ($63.79) |
| 2020 | $80.62 | 5 | Merck Sharp & Dohme Corporation ($30.99) |
| 2019 | $164.72 | 8 | Novartis Pharmaceuticals Corporation ($69.15) |
| 2018 | $49.68 | 3 | Hologic, LLC ($39.14) |
| 2017 | $210.87 | 7 | Novartis Pharmaceuticals Corporation ($122.99) |
All Payment Transactions
52 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/08/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $23.71 | General |
| 05/29/2024 | Novo Nordisk Inc | Ozempic (Drug) | Education | In-kind items and services | $32.27 | General |
| Category: Diabetes | ||||||
| 04/09/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), VAXNEUVANCE, GARDASIL 9 | Food and Beverage | In-kind items and services | $25.06 | General |
| Category: VACCINE | ||||||
| 11/16/2023 | Shield Therapeutics Inc | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $26.73 | General |
| Category: Hematology | ||||||
| 07/18/2023 | Merck Sharp & Dohme LLC | PROQUAD (Biological), VAXNEUVANCE, GARDASIL 9 | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: VACCINE | ||||||
| 03/15/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $29.78 | General |
| Category: VACCINES | ||||||
| 03/15/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $25.78 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/13/2023 | Organon LLC | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: ETONOGESTREL | ||||||
| 03/03/2023 | AbbVie Inc. | LO LOESTRIN FE (Drug) | Food and Beverage | In-kind items and services | $29.31 | General |
| Category: WOMENS HEALTH | ||||||
| 01/25/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $26.37 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/15/2022 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $37.23 | General |
| 11/10/2022 | Merck Sharp & Dohme LLC | GARDASIL 9 (Biological), ROTATEQ, PROQUAD | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: VACCINE | ||||||
| 11/02/2022 | Organon LLC | — | Food and Beverage | In-kind items and services | $19.85 | General |
| 09/21/2022 | SANOFI PASTEUR INC. | VAXELIS (Biological), MENQUADFI | Food and Beverage | In-kind items and services | $28.00 | General |
| Category: Vaccines | ||||||
| 07/13/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $24.98 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/01/2022 | Merck Sharp & Dohme LLC | GARDASIL 9 (Biological), PROQUAD, VARIVAX | Food and Beverage | In-kind items and services | $23.44 | General |
| Category: VACCINE | ||||||
| 05/26/2022 | Organon LLC | — | Food and Beverage | In-kind items and services | $16.24 | General |
| 04/06/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $21.16 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/30/2022 | Cranial Technologies, Inc | Doc Band (Device) | Food and Beverage | Cash or cash equivalent | $16.34 | General |
| Category: Cranial Orthotic | ||||||
| 03/09/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $23.42 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/11/2021 | Cranial Technologies, Inc | Doc Band (Device) | Food and Beverage | Cash or cash equivalent | $15.93 | General |
| Category: Cranial Orthotic | ||||||
| 10/26/2021 | SANOFI PASTEUR INC. | MENQUADFI (Biological), VAXELIS | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: Vaccines | ||||||
| 09/27/2021 | Organon LLC | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: CONTRACEPTIVES | ||||||
| 08/26/2021 | Merck Sharp & Dohme Corporation | GARDASIL 9 (Biological), VAXELIS | Food and Beverage | In-kind items and services | $26.00 | General |
| Category: VACCINE | ||||||
| 05/13/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: PRIMARY CARE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 285 | 463 | $124,682 | $31,702 |
| 2022 | 9 | 355 | 590 | $142,837 | $38,511 |
| 2021 | 9 | 392 | 601 | $141,659 | $41,020 |
| 2020 | 8 | 352 | 523 | $129,532 | $33,425 |
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 75 | 196 | $48,804 | $13,024 | 26.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 48 | 53 | $25,652 | $6,662 | 26.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 37 | 49 | $17,787 | $4,651 | 26.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 28 | 28 | $16,800 | $3,930 | 23.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 32 | 38 | $5,814 | $1,592 | 27.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 12 | 12 | $8,184 | $1,111 | 13.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 53 | 87 | $1,641 | $730.80 | 44.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 78 | 227 | $56,523 | $15,700 | 27.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 46 | 68 | $24,684 | $6,919 | 28.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 51 | 53 | $25,652 | $6,072 | 23.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 40 | 40 | $20,119 | $5,759 | 28.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 35 | 47 | $7,191 | $1,984 | 27.6% |
| 76700 | Complete ultrasound scan of abdomen | Office | 2022 | 11 | 11 | $4,642 | $1,104 | 23.8% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 16 | 16 | $1,600 | $342.04 | 21.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 64 | 114 | $1,026 | $337.98 | 32.9% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 14 | 14 | $1,400 | $293.44 | 21.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 79 | 203 | $50,547 | $14,789 | 29.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 67 | 96 | $35,167 | $9,163 | 26.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 51 | 58 | $28,072 | $7,095 | 25.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 41 | 41 | $16,140 | $6,011 | 37.2% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 29 | 40 | $6,120 | $1,871 | 30.6% |
| 99497 | Advance care planning by the physician or other qualified health care professional, first 30 minutes | Office | 2021 | 11 | 11 | $1,100 | $816.20 | 74.2% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2021 | 31 | 31 | $2,150 | $657.20 | 30.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 69 | 107 | $963.00 | $321.00 | 33.3% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 14 | 14 | $1,400 | $296.80 | 21.2% |
About Dr. Afshin Akhavan, DO
Dr. Afshin Akhavan, DO is a Family Medicine healthcare provider based in Los Angeles, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/29/2007. The National Provider Identifier (NPI) number assigned to this provider is 1003952797.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Afshin Akhavan, DO has received a total of $1,133 in payments from pharmaceutical and medical device companies, with $81.04 received in 2024. These payments were reported across 52 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($1,101).
As a Medicare-enrolled provider, Akhavan has provided services to 1,384 Medicare beneficiaries, totaling 2,177 services with total Medicare billing of $144,658. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Obstetrics & Gynecology, General Practice
- Location Los Angeles, CA
- Active Since 01/29/2007
- Last Updated 10/15/2014
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1003952797
Products in Payments
- ENTRESTO (Drug) $331.83
- GARDASIL 9 (Biological) $90.51
- LO LOESTRIN FE (Drug) $89.49
- NEXPLANON (Drug) $57.31
- SHINGRIX (Biological) $55.44
- Ozempic (Drug) $32.27
- Doc Band (Device) $32.27
- VAXELIS (Biological) $28.00
- ACCRUFER (Drug) $26.73
- GARDASIL (Biological) $25.06
- ATV (Device) $24.20
- QVAR (Drug) $19.68
- PNEUMOVAX 23 (Biological) $18.25
- Aptima TV (Device) $17.57
- EMGALITY (Drug) $16.68
- JANUMET (Drug) $16.67
- PREPOPIK (Drug) $16.02
- NURTEC ODT (Drug) $15.91
- PROQUAD (Biological) $15.59
- Thin prep (Device) $14.94
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Los Angeles
Dr. Pamela Kushner, M.d, M.D
Family Medicine — Payments: $1.3M
Scott Howell, Do, DO
Family Medicine — Payments: $981,460
Dr. Derrick Butler, M.d, M.D
Family Medicine — Payments: $673,383
Dr. Nader Sobh, D.o, D.O
Family Medicine — Payments: $625,381
Dr. Leonard Fromer, M.d, M.D
Family Medicine — Payments: $205,872
Miss. Jacqueline Kenney, Pa-C, PA-C
Family Medicine — Payments: $97,284